Drug Pricing Quotes

Drug company payments to doctors are a small part of a much larger strategy by Big Pharma to clean our pockets.

The public relies on the advice of doctors and leading researchers. The public has a right to know about financial relationships between those doctors and the drug companies who make the pharmaceuticals prescribed by doctors.

When Kansans go to the pharmacy to pick up their medication, they deserve a fair deal on their drug prices.

When the price of a drug rises, it becomes profitable and the target of new competition.

President Trump has exposed the dirty secret of drug pricing: There is a shadowy third player in the transaction between patients and their pharmacists: middlemen who have taken a big kickback from the drug manufacturer, which may or may not be reflected in patients' out-of-pocket costs.

My father has fought to protect people from predatory pharmaceutical companies and to make sure drug payments and kickbacks to doctors are disclosed.

I want to make sure that our bio-similars capture a huge market share and help cancer patients around the world, which we are already doing in the developing world because we didn't have access to these drugs. Biocon enjoys a large reputation of giving them high-quality cancer drug.

Federal laws against kickbacks bar pharmaceutical companies from directly giving money to patients for co-payments on the drugs they make.

When a company owns a drug, it has a responsibility to make sure that the drug is available to all who need it.

EpiPen is not unique. It falls into a category of old drugs, many of which should have long been subject to generic competition.

We've had a long wrangle with the pharmaceutical industry about parallel imports, and what we were saying is we want to make medicines and drugs as affordable as a possible to what is largely a poor population.

I've always considered making it legal for Americans to import their prescription drugs a free-trade issue. Imports create competition and keep domestic industry more responsive to consumers.

Americans pay up to 1,000 percent more to fill their prescriptions than consumers in other countries - that is an alarming statistic.

On Medicare, I would suggest ridding the system of fraud and bulk purchasing of prescription drugs, to begin with.

If you have a drug that is $100 for one course of therapy, and you know that you can charge $100,000, what should shareholders think when you say, 'I'd rather not take the heat'?

If we're going to tackle the skyrocketing cost of prescription drugs, along with so many other issues that are at the top of our community's mind, we need to reform our system and make it work for the people, not special interests and corporations.

At the end of the day, my hope is that when the new Medicare- Prescription Drug Law gets up and fully running a lot more seniors will pay a whole lot less than they do today for their much-needed medications.

The goal of re-importation is to provide American consumers with access to drugs at the world market price - not the inflated price now paid only by Americans.

The one big strategic error - which was a political error and an economic error of grand proportions - was the prescription drug bill.

It's time to stop defending a system that is clearly in dire need of reform, stop issuing reports and setting up new roadblocks, and start providing Americans with prescription drugs that are both safe and affordable.

Today, nearly 40 percent of a senior's healthcare spending is on pharmaceutical medications.

It's easy to complain that pharmaceutical companies place profits over people and apparently care more about hair loss than TB. However, many in the pharmaceutical industry would be glad for the opportunity to reorient their research toward medicines that are truly needed, provided only that such research is financially sustainable.

Pharmaceutical companies have invested hundreds of millions of dollars in new HIV/AIDS treatments not out of altruism but because they can make up those research costs in sales.

You know the pharmaceutical industry. If they are involved with any deal with the government, they are not going to lose any money.

Pharmaceutical companies are enjoying unprecedented profits and access with this Administration. Yet the Republicans' prescription drug plan for seniors has been a colossal failure, and over 43 million Americans wake up every morning without health insurance.